World’s first and only multi-condition EU MDR Class IIb regulatory approval
Discover what it means for the future of patient-centred care and research.
Read more
Read more

Join the conversation

Together we can sharpen our thinking.

FILTER BY TYPE OF CONTENT

In the news

How the UK built a world class tech talent pool

On the path to unicorn status, Huma allows doctors to monitor patients remotely through a mobile app that integrates their data into a dashboard for clinicians to monitor. Since its founding in 2011, it has grown to support a network of more than 27 million patients, and more than 3,000 hospitals and clinics.

Mar 7, 2023
In the news

Bayer taps UK digital health firm for heart risk tool

London, England-based Huma Therapeutics and Bayer have teamed up to develp an online tool where people can check their risk of getting heart disease. The tool does not replace a physician's assessment, the companies caution, but the 15-question assessment may determine if an individual is at a higher, average, or lower risk for developing heart disease.

Mar 3, 2023
In the news

Huma acquires specialised clinical research company Alcedis

Following the acquisition, leading global digital health company Huma will form an advanced clinical trials division offering digital solutions across the entire development pipeline.

Mar 3, 2023
In the news

Huma aquires Alcedis to form clinical trials division

Health tech company Huma Therapeutics is to form an advanced clinical trials division following the acquisition of Alcedis GmbH.

Mar 2, 2023
JOIN THE CONVERSATION

Discover our patents

Publications

Patents

Articles

Learn more

Sign up to our newsletter

Huma is committed to respecting your privacy, we’ll always treat your personal details with the utmost care and will never sell them to other companies for marketing purposes. You can unsubscribe at any time. Review our Privacy Policy for further information.

Keep up to date on our current work and research with the latest marketing updates from Huma, including monthly news, events and communications on products and services.

One of our team members will be in touch with you shortly.
Oops! Something went wrong while submitting the form.
For all press enquiries, please contact: Karen Birmingham, Head of PR & Communications on karen.birmingham@huma.com

London

Millbank Tower
21-24 Millbank
London SW1P 4QP
UK

For all London enquiries

ldn@huma.com

New York

The Genome Center
101 6th Avenue
New York NY 10013
USA

For all New York
enquiries

nyc@huma.com

Shanghai

Room 123, 13th Floor
Shanghai Tower
No. 501 Yincheng Middle Road
China

For all China enquiries

shg@huma.com

Munich

(DACH-Region)
Huma Therapeutics GmbH
Raboisen 32
20095 Hamburg

For all enquiries

germany@huma.comaustria@huma.comswitzerland@huma.com